首页 | 本学科首页   官方微博 | 高级检索  
     

英夫利昔治疗克罗恩病进展
引用本文:耿学斯,张志谦. 英夫利昔治疗克罗恩病进展[J]. 大连医科大学学报, 2009, 31(4): 345-347
作者姓名:耿学斯  张志谦
作者单位:福建中医学院,附属厦门市中医院,福建,厦门,361009;福建中医学院,福建,福州,350108
摘    要:近年来欧美各国采用英夫利昔治疗克罗恩病,取得了一定的进展,但目前国内相关报道仍较少。本文从诱导缓解、维持缓解、并发症治疗、常见不良反应及处理等方面介绍了英夫利昔在国外的应用进展。

关 键 词:克罗恩病  英夫利昔  诱导缓解  维持缓解  不良反应

Progression of Infliximab in the treatment of Crohn's Disease
GENG Xue-si and ZHANG Zhi-qian. Progression of Infliximab in the treatment of Crohn's Disease[J]. Journal of Dalian Medical University, 2009, 31(4): 345-347
Authors:GENG Xue-si and ZHANG Zhi-qian
Affiliation:GENG Xue-si1,ZHANG Zhi-qian2(1.Xiamen Hospital of Traditional Chinese Medicine Affiliated to Fujian College of Traditional Chinese Medicine,Xiamen 361009,China,2.Fujian College of Traditional Chinese Medicine Fujian,Fuzhou 50108,China)
Abstract:Infliximab has been used for Crohn's disease in European and American countries recently,with some progress in the treatment of the disease.But there is still little literature on this medicine right now in China.This article reviewed the progression of Infliximab in treating Crohn's disease abroad from the aspects of inducing remission,maintaining remission,treatment of complications and common adverse reactions and their management.
Keywords:crohn's disease  Infliximab  induce remission  maintain remission  adverse reaction  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号